- Home
- AKRO vs SAND Comparison
AKRO vs SAND Comparison
Compare AKRO & SAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- SAND
- Stock Information
- Founded
- AKRO 2017
- SAND 2007
- Country
- AKRO United States
- SAND Canada
- Employees
- AKRO N/A
- SAND N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- SAND
- Sector
- AKRO Health Care
- SAND
- Exchange
- AKRO Nasdaq
- SAND NYSE
- Market Cap
- AKRO 3.9B
- SAND 2.4B
- IPO Year
- AKRO 2019
- SAND N/A
- Fundamental
- Price
- AKRO $54.58
- SAND $9.41
- Analyst Decision
- AKRO Strong Buy
- SAND Buy
- Analyst Count
- AKRO 6
- SAND 4
- Target Price
- AKRO $82.50
- SAND $9.13
- AVG Volume (30 Days)
- AKRO 1.8M
- SAND 5.2M
- Earning Date
- AKRO 08-08-2025
- SAND 07-31-2025
- Dividend Yield
- AKRO N/A
- SAND 0.67%
- EPS Growth
- AKRO N/A
- SAND 32.83
- EPS
- AKRO N/A
- SAND 0.10
- Revenue
- AKRO N/A
- SAND $183,537,000.00
- Revenue This Year
- AKRO N/A
- SAND $17.55
- Revenue Next Year
- AKRO N/A
- SAND $10.62
- P/E Ratio
- AKRO N/A
- SAND $96.14
- Revenue Growth
- AKRO N/A
- SAND 2.84
- 52 Week Low
- AKRO $21.02
- SAND $4.92
- 52 Week High
- AKRO $58.40
- SAND $9.68
- Technical
- Relative Strength Index (RSI)
- AKRO 68.00
- SAND 59.45
- Support Level
- AKRO $53.05
- SAND $8.95
- Resistance Level
- AKRO $56.49
- SAND $9.43
- Average True Range (ATR)
- AKRO 2.44
- SAND 0.23
- MACD
- AKRO -0.26
- SAND -0.03
- Stochastic Oscillator
- AKRO 86.02
- SAND 96.61
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About SAND SANDSTORM GOLD LIMITED
Sandstorm Gold Ltd provides financing to companies engaged in gold mining through the gold stream and royalty. Geographically, the company has operational footprints in North America, South & Central America, Africa, and Asia & Australia. The firm's royalties include Hod Maden, Santa Elena, Chapada, Platreef, Greenstone, and Cerro Moro.